| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZNF91_0008000 | Intron-Exon-Intron | chr19:23556544-23559132 | chr19:23373742-23376330 | 273 nt | 0.4029 |
| hsa_ZNF91_0007700 | Intron-Exon-Intron | chr19:23556544-23571046 | chr19:23373742-23388244 | 250 nt | 0.4120 |
| hsa_ZNF91_0007900 | Exon-Exon | chr19:23556544-23578211 | chr19:23373742-23395409 | 308 nt | 0.4968 |
| hsa_ZNF91_0008300 | Intron-Exon-Intron | chr19:23557440-23571046 | chr19:23374638-23388244 | 250 nt | 0.4040 |
| hsa_chr19_0142900 | Intergenic-Intergenic | chr19:23576449-23576634 | chr19:23393647-23393832 | 186 nt | 0.4570 |
A study in pancreatic cancer cells demonstrated that the circZNF91 facilitates glycolysis and gemcitabine chemoresistance via the SIRT1/HIF-1α axis [Huang et al. DOI:10.3390/cells11091381].